Several recent policy proposals are placing new pressures on the 340B drug pricing program, a decades-old federal initiative many hospitals and health systems depend on to offset the costs of care for uninsured and underinsured patients. In the past few…
The Miccosukee Tribe of Indians of Florida dropped its lawsuit against major insulin manufacturers and the Big Three pharmacy benefit managers Sept. 26, according to court filings. The tribe had accused a host of defendants of fraudulent conduct, focusing on…
Pfizer has become the first drugmaker to lower the price of its prescription medications in the U.S. through a new deal with the federal government, President Donald Trump announced during a Sept. 30 media briefing. The White House is also…
Three major pharmacy organizations called to improve workplace conditions in retail and hospital pharmacies in a Sept. 29 report. The American Society of Health-System Pharmacists, American Pharmacists Association and National Association of Boards of Pharmacy published a report outlining several…
A new pilot program from the federal government has hospital and pharmacy leaders bracing for what they describe as a fundamental dismantling of the 340B drug pricing program, which many health systems rely on to sustain care for their most…
Middletown, Conn.-based Middlesex Health opened the system’s first retail and specialty pharmacy on Sept. 30. Three notes: 1. The 1,867- square-foot pharmacy is located at Middlesex Hospital, also in Middletown. 2. Alongside regular prescription services, the pharmacy will also offer…
After serving Yale New Haven (Conn.) Health for more than 20 years, LeeAnn Miller, PharmD, is joining Cencora as vice president of business development and growth. Dr. Miller will be part of the Cencora’s Accelerate Pharmacy Solutions team, where she…
Cosentyx, an autoimmune disease therapy that cost the healthcare industry $7.7 billion in 2024, will be offered at a 55% discount beginning in November. The drug’s manufacturer, Novartis, said Sept. 29 it plans to launch a direct-to-patient platform on Nov.…
Here are six new drug shortages and discontinuations, according to drug supply databases from the FDA and American Society of Health-System Pharmacists.
With tariffs set to take effect Oct. 1 on certain pharmaceuticals, major drugmakers have been accelerating investments in U.S. manufacturing. Here are five updates:
